Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan + amlodipine versus olmesartan + hydrochlorothiazide for endothelial protection in hypertensive at-risk patients
2009-017010-68Phase 4Completed
- Sponsor
- University Medical Center Mainz
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of telmisartan, amlodipine, olmesartan and hydrochlorothiazide in hypertension (HTN) (2 arms), sponsored by University Medical Center Mainz. Primary endpoint: Change in endothelial function measured by flow-mediated dilation. Started Apr 2010; status: completed.
02
Drugs
telmisartanamlodipineolmesartanhydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2009-017010-68.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017010-68.